Skip to Content

THIS END UP DEPAKOTE SPRINKLE 125MG (Divalproex sodium delayed-release (sprinkle) 125 mg)

Pill with imprint THIS END UP DEPAKOTE SPRINKLE 125MG is Blue / White, Capsule-shape and has been identified as Divalproex sodium delayed-release (sprinkle) 125 mg. It is supplied by Sandoz Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for THIS END UP DEPAKOTE SPRINKLE 125MG

Divalproex sodium delayed-release (sprinkle)

Imprint
THIS END UP DEPAKOTE SPRINKLE 125MG
Strength
125 mg
Color
Blue / White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00781-2243 Sandoz Inc.
00074-6114 Abbott Laboratories
55289-0991 PDRX Pharmaceuticals Inc. (repackager)
49999-0942 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "THIS END UP DEPAKOTE SPRINKLE 125MG"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.